{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:41:00Z","timestamp":1785148860050,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Mannheim der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Emerging evidence suggests that inflammatory conditions and comorbidities have a prognostic impact on patients with heart failure with mildly reduced ejection fraction (HFmrEF) in particular. This study aims to investigate the influence of rheumatic comorbidities on clinical outcomes in HFmrEF patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study included patients hospitalized with HFmrEF at a tertiary care center in Germany between January 2016 and December 2022. Patients hospitalized with HFmrEF were divided in two groups \u2013 with and without rheumatic diseases \u2013 and were compared with regard to the primary endpoint all-cause mortality at 30\u00a0months, as well as the key secondary endpoint HF-related rehospitalization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>From a total of 2,184 patients with HFmrEF, 47 (2.2%) were diagnosed with a rheumatic disease. There was no significant difference in distribution of age (median 75\u00a0years vs. 76\u00a0years, p\u2009=\u20090.532), sex (males: 55.3% vs. 64.8%; p\u2009=\u20090.181) and cardiovascular comorbidities between patients with and without rheumatic diseases. The presence of rheumatic disease was not associated with the risk of all-cause mortality at 30\u00a0months (HR\u2009=\u20090.765; 95% CI 0.432\u20131.354; p\u2009=\u20090.358). However, patients with rheumatic diseases were associated with a higher risk of rehospitalization for HF at 30\u00a0months (HR\u2009=\u20092.088; 95% CI 1.171\u20133.723; p\u2009=\u20090.013). This association was still observed after multivariable adjustment (HR\u2009=\u20092.360; p\u2009=\u20090.006).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Patients with HFmrEF and coexisting rheumatic diseases did not exhibit increased 30-month all-cause mortality. However, the risk of rehospitalization was significantly higher in patients with rheumatic diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00392-025-02740-2","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:17:24Z","timestamp":1756282644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction"],"prefix":"10.1007","author":[{"given":"Michelle","family":"Goertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Dudda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abumayyaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning Johann","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald F.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Duerschmied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Behnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"2740_CR1","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1001\/jama.2012.14785","volume":"308","author":"LH Lund","year":"2012","unstructured":"Lund LH, Benson L, Dahlstr\u00f6m U, Edner M (2012) Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. JAMA 308:2108\u20132117. https:\/\/doi.org\/10.1001\/jama.2012.14785","journal-title":"JAMA"},{"key":"2740_CR2","unstructured":"Bundesamt S (2023) Die 10 h\u00e4ufigsten Todesf\u00e4lle durch Herz-Kreislauf-Erkrankungen. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Gesundheit\/Todesursachen\/Tabellen\/sterbefaelle-herz-kreislauf-erkrankungen-insgesamt.html"},{"key":"2740_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/ejhf.159","volume":"16","author":"CS Lam","year":"2014","unstructured":"Lam CS, Solomon SD (2014) The middle child in heart failure: heart failure with mid-range ejection fraction (40\u201350%). Eur J Heart Fail 16:1049\u20131055. https:\/\/doi.org\/10.1002\/ejhf.159","journal-title":"Eur J Heart Fail"},{"key":"2740_CR4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C et al (2017) Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19:1574\u20131585. https:\/\/doi.org\/10.1002\/ejhf.813","journal-title":"Eur J Heart Fail"},{"key":"2740_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3899\/jrheum.100979","volume":"38","author":"E Myasoedova","year":"2011","unstructured":"Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, Therneau TM, Gabriel SE (2011) The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 38:1601\u20131606. https:\/\/doi.org\/10.3899\/jrheum.100979","journal-title":"J Rheumatol"},{"key":"2740_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014661","volume":"9","author":"MJ Ahlers","year":"2020","unstructured":"Ahlers MJ, Lowery BD, Farber-Eger E, Wang TJ, Bradham W, Ormseth MJ, Chung CP, Stein CM, Gupta DK (2020) Heart failure risk associated with rheumatoid arthritis-related chronic inflammation. J Am Heart Assoc 9:e014661. https:\/\/doi.org\/10.1161\/JAHA.119.014661","journal-title":"J Am Heart Assoc"},{"key":"2740_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/art.20855","volume":"52","author":"PJ Nicola","year":"2005","unstructured":"Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52:412\u2013420. https:\/\/doi.org\/10.1002\/art.20855","journal-title":"Arthritis Rheum"},{"key":"2740_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/hypertensionaha.109.148635","volume":"56","author":"GC Mel\u00e9ndez","year":"2010","unstructured":"Mel\u00e9ndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL (2010) Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56:225\u2013231. https:\/\/doi.org\/10.1161\/hypertensionaha.109.148635","journal-title":"Hypertension"},{"key":"2740_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00393-022-01305-2","volume":"82","author":"K Albrecht","year":"2023","unstructured":"Albrecht K, Binder S, Minden K, Poddubnyy D, Regierer AC, Strangfeld A, Callhoff J (2023) Systematisches Review zur Sch\u00e4tzung der Pr\u00e4valenz entz\u00fcndlich rheumatischer Erkrankungen in Deutschland. Z Rheumatol 82:727\u2013738. https:\/\/doi.org\/10.1007\/s00393-022-01305-2","journal-title":"Z Rheumatol"},{"key":"2740_CR10","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690\u20131697. https:\/\/doi.org\/10.1002\/art.24092","journal-title":"Arthritis Rheum"},{"key":"2740_CR11","first-page":"1196","volume":"30","author":"DJ Watson","year":"2003","unstructured":"Watson DJ, Rhodes T, Guess HA (2003) All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK general practice research database. J Rheumatol 30:1196\u20131202","journal-title":"J Rheumatol"},{"issue":"4","key":"2740_CR12","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1161\/CIRCULATIONAHA.114.012900","volume":"131","author":"M Behnes","year":"2015","unstructured":"Behnes M, Akin I, Borggrefe M, Traunwieser D, Neuser H, Mashayekhi K (2015Jan 27) Effect of tumor necrosis factor inhibitor treatment on proximal right coronary chronic total occlusion in a patient with rheumatoid arthritis. Circulation 131(4):e26\u2013e28","journal-title":"Circulation"},{"key":"2740_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.101086","volume":"47","author":"S Sagheer","year":"2022","unstructured":"Sagheer S, Deka P, Pathak D, Khan U, Zaidi SH, Akhlaq A, Blankenship J, Annis A (2022) Clinical outcomes of acute myocardial infarction hospitalizations with systemic lupus erythematosus: an analysis of nationwide readmissions database. Curr Probl Cardiol 47:101086. https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.101086","journal-title":"Curr Probl Cardiol"},{"key":"2740_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/07853890109002058","volume":"33","author":"H Koukkunen","year":"2001","unstructured":"Koukkunen H, Penttil\u00e4 K, Kemppainen A, Halinen M, Penttila I, Rantanen T, Py\u00f6r\u00e4l\u00e4 K (2001) C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 33:37\u201347. https:\/\/doi.org\/10.3109\/07853890109002058","journal-title":"Ann Med"},{"key":"2740_CR15","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/01.Cir.0000097109.90783.Fc","volume":"108","author":"M Cesari","year":"2003","unstructured":"Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M (2003) Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 108:2317\u20132322. https:\/\/doi.org\/10.1161\/01.Cir.0000097109.90783.Fc","journal-title":"Circulation"},{"key":"2740_CR16","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/01.cir.0000057810.48709.f6","volume":"107","author":"RS Vasan","year":"2003","unstructured":"Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D\u2019Agostino RB (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107:1486\u20131491. https:\/\/doi.org\/10.1161\/01.cir.0000057810.48709.f6","journal-title":"Circulation"},{"key":"2740_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000338166","volume":"122","author":"L Gullestad","year":"2012","unstructured":"Gullestad L, Ueland T, Vinge LE, Finsen A, Yndestad A, Aukrust P (2012) Inflammatory cytokines in heart failure: mediators and markers. Cardiology 122:23\u201335. https:\/\/doi.org\/10.1159\/000338166","journal-title":"Cardiology"},{"key":"2740_CR18","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1016\/j.febslet.2011.06.006","volume":"585","author":"AM Quirke","year":"2011","unstructured":"Quirke AM, Fisher BA, Kinloch AJ, Venables PJ (2011) Citrullination of autoantigens: upstream of TNF\u03b1 in the pathogenesis of rheumatoid arthritis. FEBS Lett 585:3681\u20133688. https:\/\/doi.org\/10.1016\/j.febslet.2011.06.006","journal-title":"FEBS Lett"},{"issue":"15","key":"2740_CR19","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.3390\/ijms21155238","volume":"21","author":"F Pandolfi","year":"2020","unstructured":"Pandolfi F, Franza L, Carusi V, Altamura S, Andriollo G, Nucera E (2020) Interleukin-6 in rheumatoid arthritis. Int J Mol Sci 21(15):5238. https:\/\/doi.org\/10.3390\/ijms21155238","journal-title":"Int J Mol Sci"},{"key":"2740_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.hfc.2013.10.003","volume":"10","author":"K Wright","year":"2014","unstructured":"Wright K, Crowson CS, Gabriel SE (2014) Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. Heart Fail Clin 10:339\u2013352. https:\/\/doi.org\/10.1016\/j.hfc.2013.10.003","journal-title":"Heart Fail Clin"},{"key":"2740_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.1540-8167.2001.00294.x","volume":"12","author":"D Aronson","year":"2001","unstructured":"Aronson D, Mittleman MA, Burger AJ (2001) Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 12:294\u2013300. https:\/\/doi.org\/10.1046\/j.1540-8167.2001.00294.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2740_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ejim.2013.02.009","volume":"24","author":"PE Lazzerini","year":"2013","unstructured":"Lazzerini PE, Acampa M, Capecchi PL, Hammoud M, Maffei S, Bisogno S, Barreca C, Galeazzi M, Laghi-Pasini F (2013) Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med 24:368\u2013374. https:\/\/doi.org\/10.1016\/j.ejim.2013.02.009","journal-title":"Eur J Intern Med"},{"issue":"4","key":"2740_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/toxins12040227","volume":"12","author":"T Ebert","year":"2020","unstructured":"Ebert T, Pawelzik SC, Witasp A, Arefin S, Hobson S, Kublickiene K, Shiels PG, B\u00e4ck M, Stenvinkel P (2020) Inflammation and premature ageing in chronic kidney disease. Toxins 12(4):227. https:\/\/doi.org\/10.3390\/toxins12040227","journal-title":"Toxins"},{"issue":"12","key":"2740_CR24","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/cells12121581","volume":"12","author":"SP Kadatane","year":"2023","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R (2023) The Role of Inflammation in CKD. Cells 12(12):1581. https:\/\/doi.org\/10.3390\/cells12121581","journal-title":"Cells"},{"key":"2740_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1055\/s-0030-1251912","volume":"135","author":"C Zugck","year":"2010","unstructured":"Zugck C, M\u00fcller A, Helms TM, Wildau HJ, Becks T, Hacker J, Haag S, Goldhagen K, Schwab JO (2010) Gesundheits\u00f6konomische Bedeutung der Herzinsuffizienz: Analyse bundesweiter Daten. Dtsch Med Wochenschr 135:633\u2013638. https:\/\/doi.org\/10.1055\/s-0030-1251912","journal-title":"Dtsch Med Wochenschr"},{"key":"2740_CR26","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1002\/ehf2.12792","volume":"7","author":"J Huusko","year":"2020","unstructured":"Huusko J, Tuominen S, Studer R, Corda S, Proudfoot C, Lassenius M, Ukkonen H (2020) Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure. ESC Heart Fail 7:2406\u20132417. https:\/\/doi.org\/10.1002\/ehf2.12792","journal-title":"ESC Heart Fail"},{"key":"2740_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152727","volume":"73","author":"SR Chandrupatla","year":"2025","unstructured":"Chandrupatla SR, Singh JA (2025) Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure. Semin Arthritis Rheum 73:152727. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152727","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02740-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02740-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02740-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:29:01Z","timestamp":1757442541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02740-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":27,"alternative-id":["2740"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02740-2","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The registry was carried out according to the principles of the declaration of Helsinki and was approved by the medical ethics committee II of the Medical Faculty Mannheim, University of Heidelberg, Germany (ethical approval code: 2022\u2013818). No written informed consent was necessary for the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}